The Global Medical Director, Spinal Muscular Atrophy (SMA) will serve as a strategic partner and expert medical leader, guiding development, launch planning, execution, and ongoing support for Biogen's SMA program. The goal is to drive meaningful improvements in patient outcomes. As a key member of the global SMA medical affairs team, the Medical Director will help develop and implement the global medical strategy, reinforcing Biogen's leadership within the SMA medical community.